These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-activity relationships in the series of eremomycin carboxamides. Miroshnikova OV; Printsevskaya SS; Olsufyeva EN; Pavlov AY; Nilius A; Hensey-Rudloff D; Preobrazhenskaya MN J Antibiot (Tokyo); 2000 Mar; 53(3):286-93. PubMed ID: 10819300 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria. Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Isakova EB; Reznikova MI; Goldman RC; Branstrom AA; Baizman ER; Longley CB; Sztaricskai F; Batta G; Preobrazhenskaya MN J Med Chem; 2002 Mar; 45(6):1340-7. PubMed ID: 11882003 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial Conjugates of Kanamycin A with Vancomycin and Eremomycin: Biological Activity and a New MS-Fragmentation Pattern of Cbz-Protected Amines. Solyev PN; Isakova EB; Olsufyeva EN Antibiotics (Basel); 2023 May; 12(5):. PubMed ID: 37237799 [TBL] [Abstract][Full Text] [Related]
6. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis. Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397 [TBL] [Abstract][Full Text] [Related]
7. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974 [TBL] [Abstract][Full Text] [Related]
8. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin. Printsevskaya SS; Solovieva SE; Olsufyeva EN; Mirchink EP; Isakova EB; De Clercq E; Balzarini J; Preobrazhenskaya MN J Med Chem; 2005 Jun; 48(11):3885-90. PubMed ID: 15916441 [TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria]. Malkova IV; Borisova OK; Pavlova MV; Zemlianitskaia EP; Sergeeva TI Antibiot Khimioter; 1991 Apr; 36(4):17-20. PubMed ID: 1654046 [TBL] [Abstract][Full Text] [Related]
11. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin]. Malikova IV Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344 [TBL] [Abstract][Full Text] [Related]
13. [Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity]. Filippos'iants ST; Malkova IV; Gol'dberg LE Antibiot Khimioter; 1989 Jul; 34(7):523-6. PubMed ID: 2530944 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics. Olsuf'eva EN; Preobrazhenskaya MN Russ J Bioorg Chem; 2006; 32(4):303-322. PubMed ID: 32214779 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides. Tevyashova AN; Bychkova EN; Korolev AM; Isakova EB; Mirchink EP; Osterman IA; Erdei R; Szücs Z; Batta G Bioorg Med Chem Lett; 2019 Jan; 29(2):276-280. PubMed ID: 30473176 [TBL] [Abstract][Full Text] [Related]
16. [Study of dimerization of polysynthetic derivatives of the antibiotic eremomycin by ESI MS and its role in elucidating antibacterial activity]. Mirgorodskaia OA; Olsuf'eva EN; Kolume DE; Joergensen TJ; Roepstorff P; Pavlov AIu; Miroshnikova OV; Preobrazhenskaia MN Bioorg Khim; 2000 Aug; 26(8):631-40. PubMed ID: 11041003 [TBL] [Abstract][Full Text] [Related]
17. [Eremomycin--a new antibiotic of the polycyclic glycopeptide group]. Gauze GF; Brazhnikova MG; Lomakina NN; Gol'dberg LE; Laĭko AV Antibiot Khimioter; 1989 May; 34(5):348-52. PubMed ID: 2742419 [TBL] [Abstract][Full Text] [Related]
18. [Study of the activity of a new glycopeptide antibiotic eremomycin combined with tobramycin against Staphylococci in vitro]. Iakushkina IV; Malkova IV; Prozorova IN Antibiot Khimioter; 1988 May; 33(5):342-5. PubMed ID: 3415389 [TBL] [Abstract][Full Text] [Related]
19. Bacterial Cell Wall Analogue Peptides Control the Oligomeric States and Activity of the Glycopeptide Antibiotic Eremomycin: Solution NMR and Antimicrobial Studies. Izsépi L; Erdei R; Tevyashova AN; Grammatikova NE; Shchekotikhin AE; Herczegh P; Batta G Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33499349 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles. Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]